Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local lidocaine injection to prevent acute postoperative pain after breast surgery
2025-521162-10-00Phase 4Authorised
- Sponsor
- Consorci Sanitari Integral
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of lidocaine in breast cancer and acute postoperative pain, sponsored by Consorci Sanitari Integral. Primary endpoints: Acute postoperative pain intensity at rest and Acute postoperative pain intensity with movement. Planned start Feb 2025; status: authorised.
02
Drugs
lidocaine
03
Conditions
breast canceracute postoperative pain
Beyond the preview
Go deeper on 2025-521162-10-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-521162-10-00.